Migraine
Not recruitingStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
- Disease:Migraine
- Substances:Lu Ag09222
Germany- Participants:18–64 years
- Substances:Lu Ag09222
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Haag in Obb, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on atrial fibrillation patients with a history of intracranial hemorrhage, evaluating new therapeutic approaches for stroke prevention and management.
The research aims to improve treatment strategies for high-risk cardiac patients with complex medical histories, particularly those requiring careful balance of blood clotting prevention and bleeding risk.
Investigation of outcomes in patients with cerebrovascular conditions, specifically examining the intersection of neurological bleeding events and cardiac arrhythmias.
These trials seek to establish safer treatment protocols for patients who have experienced both cardiac and neurological complications.
Studies evaluating optimal medical therapy approaches for patients with complex cardiovascular conditions requiring careful risk assessment.
Research focuses on developing evidence-based strategies for managing high-risk patients with multiple medical conditions requiring balanced therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.